Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Cancer, Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT01696994
What this trial is testing

Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)

Who this might be right for
Ovarian CarcinomaOvarian Germ Cell Tumor
National Cancer Institute (NCI) 78,216
Early research (Phase 1)Looking for participantsNCT04329494
What this trial is testing

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Who this might be right for
Clinical Stage IV Gastric Cancer AJCC v8Clinical Stage IVA Gastric Cancer AJCC v8Clinical Stage IVB Gastric Cancer AJCC v8+24 more
City of Hope Medical Center 49
Early research (Phase 1)Study completedNCT04672460
What this trial is testing

A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsSolid TumorsOvarian Cancer+5 more
Pfizer 73
Testing effectiveness (Phase 2)Ended earlyNCT03127098
What this trial is testing

QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer

Who this might be right for
Thyroid CancerColon CancerOvarian Cancer+3 more
NantCell, Inc. 3
Early research (Phase 1)Study completedNCT02729298
What this trial is testing

First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsEGFR Positive Non-small Cell Lung CancerColorectal Carcinoma+2 more
Sumitomo Pharma America, Inc. 177
Testing effectiveness (Phase 2)Looking for participantsNCT06380816
What this trial is testing

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

Who this might be right for
Advanced Solid TumoursSquamous Cell Carcinoma of Head and NeckCarcinoma, Non-Small-Cell Lung+8 more
Cancer Research UK 167
Not applicableActive Not RecruitingNCT00579163
What this trial is testing

Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsColonic Neoplasms+4 more
Memorial Sloan Kettering Cancer Center 992
Early research (Phase 1)Study completedNCT05788484
What this trial is testing

CDX-585 in Patients With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerGastric CancerHead and Neck Cancer+11 more
Celldex Therapeutics 20
Early research (Phase 1)Ended earlyNCT05395052
What this trial is testing

FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Who this might be right for
Non Small Cell Lung CancerColorectal CancerBreast Cancer+4 more
Fate Therapeutics 5
Early research (Phase 1)Looking for participantsNCT06242470
What this trial is testing

MGC026 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced CancerMetastatic Cancer+19 more
MacroGenics 250
Testing effectiveness (Phase 2)Study completedNCT03241173
What this trial is testing

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced Malignancies
Incyte Biosciences International Sàrl 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267
What this trial is testing

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

Who this might be right for
Breast CancerCholangiocarcinomaColorectal Cancer+13 more
Hoffmann-La Roche 534
Testing effectiveness (Phase 2)Ended earlyNCT03610490
What this trial is testing

Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma

Who this might be right for
Malignant Solid NeoplasmMetastatic Colorectal AdenocarcinomaMetastatic Ovarian Carcinoma+9 more
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)WithdrawnNCT04464967
What this trial is testing

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Who this might be right for
Advanced Solid TumorMetastatic CancerHER2-positive Breast Cancer+14 more
NKGen Biotech, Inc.
Early research (Phase 1)Study completedNCT01770353
What this trial is testing

MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

Who this might be right for
Solid TumorsER/PR Positive Breast CancerTriple Negative Breast Cancer+1 more
Ipsen 45
Not applicableUnknownNCT04145388
What this trial is testing

Family History Study on Cancer Risk

Who this might be right for
Lynch SyndromeColorectal CancerBreast Cancer+3 more
Kaiser Permanente 18,623
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Not applicableStudy completedNCT05461430
What this trial is testing

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Who this might be right for
Pleural Effusion, MalignantAscites, MalignantCarcinoma+29 more
Travera Inc 72
Testing effectiveness (Phase 2)Looking for participantsNCT06526819
What this trial is testing

SMP-3124LP in Adults With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Sumitomo Pharma America, Inc. 120
Early research (Phase 1)Study completedNCT03454451
What this trial is testing

CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers

Who this might be right for
Non-Small Cell Lung CancerRenal Cell CancerColorectal Cancer+10 more
Corvus Pharmaceuticals, Inc. 117
Next Page